R
Ramón Paniagua
Researcher at Mexican Social Security Institute
Publications - 79
Citations - 2903
Ramón Paniagua is an academic researcher from Mexican Social Security Institute. The author has contributed to research in topics: Peritoneal dialysis & Kidney disease. The author has an hindex of 24, co-authored 76 publications receiving 2732 citations.
Papers
More filters
Journal ArticleDOI
Effects of Increased Peritoneal Clearances on Mortality Rates in Peritoneal Dialysis: ADEMEX, a Prospective, Randomized, Controlled Trial
Ramón Paniagua,Dante Amato,Edward F. Vonesh,Ricardo Correa-Rotter,Alfonso Ramos,John Moran,Salim Mujais +6 more
TL;DR: Evidence is provided that increases in peritoneal small-solute clearances within the range studied have a neutral effect on patient survival, even when the groups are stratified according to a variety of factors known to affect survival.
Journal ArticleDOI
NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients
Ramón Paniagua,María-de-Jesús Ventura,Marcela Ávila-Díaz,Héctor Hinojosa-Heredia,Antonio Méndez-Durán,Alfonso M. Cueto-Manzano,Alejandra Cisneros,Alfonso Ramos,Clara Madonia-Juseino,Francisco Belio-Caro,F Garcia-Contreras,Pedro Trinidad-Ramos,Rosario Vázquez,Begoña Ilabaca,Guadalupe Alcántara,Dante Amato +15 more
TL;DR: NT-proBNP is a reliable predictor of death risk independently of the effect of dialysis modality on fluid volume control, and the presence of other clinical and biochemical markers recognized as risk factors for all-cause and cardiovascular mortality.
Journal Article
Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus.
TL;DR: Investigation of the hypothalamic-pituitary-gonadal axis in male patients with systemic lupus erythematosus found a decrease in the pituitary response to LH-RH stimulation; this low response could also be a hormonal manifestation of hyperprolactinemia.
Journal ArticleDOI
Prevalence of chronic kidney disease in an urban Mexican population.
Dante Amato,Cleto Álvarez-Aguilar,Rutila Castaneda-Limones,Ernesto Rodríguez,Marcela Ávila-Díaz,Francisco Arreola,Anel Gomez,Hiram Ballesteros,Raquel Becerril,Ramón Paniagua +9 more
TL;DR: Chronic kidney disease prevalence in this population is similar to that seen in industrialized countries, and only l out of 4 patients requiring renal replacement therapy in the country currently has access to it.
Journal ArticleDOI
Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients
Ramón Paniagua,María-de-Jesús Ventura,Marcela Ávila-Díaz,Alejandra Cisneros,Marlén Vicenté-Martínez,María-del-Carmen Furlong,Zuzel García-González,Diana Villanueva,Oscar Orihuela,María-del-Carmen Prado-Uribe,Guadalupe Alcántara,Dante Amato +11 more
TL;DR: Icodextrin represents a significant advantage in the management of high transport diabetic patients on PD, improving peritoneal UF and fluid control and reducing the burden of glucose overexposure, thereby facilitating metabolic control.